(Q46192300)

20 December 2017

title

Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide (English)

1 reference

20 December 2017

0 references

Zhang W

1

1 reference

20 December 2017

Johnson BR

series ordinal

2

1 reference

20 December 2017

Bjornsson TD

series ordinal

3

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

20 December 2017

published in

Life Sciences

1 reference

20 December 2017

volume

60

1 reference

20 December 2017

issue

25

1 reference

20 December 2017

page(s)

2323-2332

1 reference

20 December 2017

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Transglutaminase activity in rat brain: characterization, distribution, and changes with age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Transglutaminase activity in primary and subcultured rat astroglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Cellular transglutaminases in neural development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Clinical trial of indomethacin in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Intramuscular desferrioxamine in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900288-9

10.1016/S0024-3205(97)00288-9

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017